Clearly, AR does influence BC biology, and high AR relative to ER levels can serve as an independent predictor of response to anti-estrogen therapies, perhaps by identifying tumors poised to escape ER-directed therapies and switch to survival dependent on androgens and AR. The gene discussed is ESR1; the disease is breast cancer.